Protocol Ledger

NCT04924322 · Phase II/III · RECRUITING

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Interventional Phase II/III clinical trial protocol NCT04924322 sponsored by Yale University in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-05-11 Enrollment: 258 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04924322
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)258 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04924322
Protocol FieldVerified Registry Value
NCT IdentifierNCT04924322
Consolidated Lead SponsorYale University
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment258 participants (ESTIMATED)
Registered Start Date2022-05-11
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI